
By developing a non-invasive blood test for endometriosis, Bowerman is attacking a diagnostic gap that forces 200 million women to wait an average of 7–10 years — and currently requires surgery — just to confirm they have the disease.
Heather Bowerman founded DotLab, a medical technology company developing a non-invasive blood test for endometriosis, a chronic disease that currently requires surgical laparoscopy for definitive diagnosis and averages 7-10 years from symptom onset to diagnosis.
Bowerman holds degrees from UC Berkeley and Stanford Graduate School of Business, and was named to Forbes 30 Under 30 for healthcare.

An invitation, extended to Powered readers.